Cargando…
Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid
Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by low efficiency. The epigenetic modifications established during cellular differentiation are a major factor determining this low efficiency as they act as epigenetic barriers restricting reprogramming of somatic nuclei. I...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069182/ https://www.ncbi.nlm.nih.gov/pubmed/24959750 http://dx.doi.org/10.1371/journal.pone.0101022 |
_version_ | 1782322526006804480 |
---|---|
author | Sangalli, Juliano Rodrigues Chiaratti, Marcos Roberto De Bem, Tiago Henrique Camara de Araújo, Reno Roldi Bressan, Fabiana Fernandes Sampaio, Rafael Vilar Perecin, Felipe Smith, Lawrence Charles King, Willian Allan Meirelles, Flávio Vieira |
author_facet | Sangalli, Juliano Rodrigues Chiaratti, Marcos Roberto De Bem, Tiago Henrique Camara de Araújo, Reno Roldi Bressan, Fabiana Fernandes Sampaio, Rafael Vilar Perecin, Felipe Smith, Lawrence Charles King, Willian Allan Meirelles, Flávio Vieira |
author_sort | Sangalli, Juliano Rodrigues |
collection | PubMed |
description | Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by low efficiency. The epigenetic modifications established during cellular differentiation are a major factor determining this low efficiency as they act as epigenetic barriers restricting reprogramming of somatic nuclei. In this regard, most factors that promote chromatin decondensation, including histone deacetylase inhibitors (HDACis), have been found to increase nuclear reprogramming efficiency, making their use common to improve SCNT rates. Herein we used valproic acid (VPA) in SCNT to test whether the treatment of nuclear donor cells with this HDACi improves pre- and post-implantation development of cloned cattle. We found that the treatment of fibroblasts with VPA increased histone acetylation without affecting DNA methylation. Moreover, the treatment with VPA resulted in increased expression of IGF2R and PPARGC1A, but not of POU5F1. However, when treated cells were used as nuclear donors no difference of histone acetylation was found after oocyte reconstruction compared to the use of untreated cells. Moreover, shortly after artificial activation the histone acetylation levels were decreased in the embryos produced with VPA-treated cells. With respect to developmental rates, the use of treated cells as donors resulted in no difference during pre- and post-implantation development. In total, five clones developed to term; three produced with untreated cells and two with VPA-treated cells. Among the calves from treated group, one stillborn calf was delivered at day 270 of gestation whereas the other one was delivered at term but died shortly after birth. Among the calves from the control group, one died seven days after birth whereas the other two are still alive and healthy. Altogether, these results show that in spite of the alterations in fibroblasts resulting from the treatment with VPA, their use as donor cells in SCNT did not improve pre- and post-implantation development of cloned cattle. |
format | Online Article Text |
id | pubmed-4069182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40691822014-06-27 Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid Sangalli, Juliano Rodrigues Chiaratti, Marcos Roberto De Bem, Tiago Henrique Camara de Araújo, Reno Roldi Bressan, Fabiana Fernandes Sampaio, Rafael Vilar Perecin, Felipe Smith, Lawrence Charles King, Willian Allan Meirelles, Flávio Vieira PLoS One Research Article Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by low efficiency. The epigenetic modifications established during cellular differentiation are a major factor determining this low efficiency as they act as epigenetic barriers restricting reprogramming of somatic nuclei. In this regard, most factors that promote chromatin decondensation, including histone deacetylase inhibitors (HDACis), have been found to increase nuclear reprogramming efficiency, making their use common to improve SCNT rates. Herein we used valproic acid (VPA) in SCNT to test whether the treatment of nuclear donor cells with this HDACi improves pre- and post-implantation development of cloned cattle. We found that the treatment of fibroblasts with VPA increased histone acetylation without affecting DNA methylation. Moreover, the treatment with VPA resulted in increased expression of IGF2R and PPARGC1A, but not of POU5F1. However, when treated cells were used as nuclear donors no difference of histone acetylation was found after oocyte reconstruction compared to the use of untreated cells. Moreover, shortly after artificial activation the histone acetylation levels were decreased in the embryos produced with VPA-treated cells. With respect to developmental rates, the use of treated cells as donors resulted in no difference during pre- and post-implantation development. In total, five clones developed to term; three produced with untreated cells and two with VPA-treated cells. Among the calves from treated group, one stillborn calf was delivered at day 270 of gestation whereas the other one was delivered at term but died shortly after birth. Among the calves from the control group, one died seven days after birth whereas the other two are still alive and healthy. Altogether, these results show that in spite of the alterations in fibroblasts resulting from the treatment with VPA, their use as donor cells in SCNT did not improve pre- and post-implantation development of cloned cattle. Public Library of Science 2014-06-24 /pmc/articles/PMC4069182/ /pubmed/24959750 http://dx.doi.org/10.1371/journal.pone.0101022 Text en © 2014 Sangalli et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sangalli, Juliano Rodrigues Chiaratti, Marcos Roberto De Bem, Tiago Henrique Camara de Araújo, Reno Roldi Bressan, Fabiana Fernandes Sampaio, Rafael Vilar Perecin, Felipe Smith, Lawrence Charles King, Willian Allan Meirelles, Flávio Vieira Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid |
title | Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid |
title_full | Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid |
title_fullStr | Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid |
title_full_unstemmed | Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid |
title_short | Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid |
title_sort | development to term of cloned cattle derived from donor cells treated with valproic acid |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069182/ https://www.ncbi.nlm.nih.gov/pubmed/24959750 http://dx.doi.org/10.1371/journal.pone.0101022 |
work_keys_str_mv | AT sangallijulianorodrigues developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT chiarattimarcosroberto developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT debemtiagohenriquecamara developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT dearaujorenoroldi developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT bressanfabianafernandes developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT sampaiorafaelvilar developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT perecinfelipe developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT smithlawrencecharles developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT kingwillianallan developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid AT meirellesflaviovieira developmenttotermofclonedcattlederivedfromdonorcellstreatedwithvalproicacid |